Integra LifeSciences Holdings Corporation Financials

Market Capitalization $1.98 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	66.48
Forward PE	10.16
Price to Sales TTM	$1.26
Price to Book MRQ	$1.30
Enterprise to Revenue	2.36
Enterprise to EBITDA	11.42

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	-0.42%
Operating Margin	6.60%
Return on Assets TTM	3.02%
Return on Equity TTM	-0.42%

Income Statement

Revenue TTM	$1,564,920,064
Revenue per Share TTM	$20.23
Quarterly Revenue Growth	-0.40%
Gross Profit TTM	$927,916,032
EBITDA	$187,769,000
Net Income to Common TTM	$-6,545,000
Diluted EPS TTM	$-0.09
Quarterly Earnings Growth YoY	-0.41%

Balance Sheet

Total Cash MRQ	$277,598,016
Total Cash per Share MRQ	$3.60
Total Debt MRQ	$
Total Debt to Equity MRQ	130.88
Current Ratio MRQ	1.21
Book Value per Share MRQ	$19.73

Cash Flow

Operating Cash Flow TTM	$137,392,000
Levered Free Cash Flow TTM	$92,906,752

IART Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	77,163,504
Float Shares	66,016,481
Avg 10 Volume	590,050
Avg 30 Volume	None
Shares Short	3,242,101
Short Ratio	6.14
Short % of Shares	4.88%
% Held by Insiders	14.25%
% Held by Institutions	93.10%

Stock Price Summary

Beta	1.08
Fifty Two Week Low	$16.81
Fifty Two Week High	$45.42
Fifty Two Week Change	-60.77%
Day 50 MA	$23.38
Day 200 MA	$24.51

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date	2017-01-04